LTR Pharma (ASX:LTP) Total Assets: A$27.32 Mil (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.56
View Full Analysis

What is LTR Pharma Total Assets?

LTR Pharma ASX:LTP -4.27% 15 Total Assets is A$27.32 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100.

LTR Pharma's Total Assets for the quarter that ended in Dec. 2025 was A$27.32 Mil.

During the past 12 months, LTR Pharma's average Total Assets Growth Rate was 133.30% per year. During the past 3 years, the average Total Assets Growth Rate was 6.40% per year.

During the past 5 years, LTR Pharma's highest 3-Year average Total Assets Growth Rate was 6.40%. The lowest was -1.20%. And the median was 2.60%.

Total Assets is connected with ROA %. LTR Pharma's annualized ROA % for the quarter that ended in Dec. 2025 was -38.71%. Total Assets is also linked to Revenue through Asset Turnover. LTR Pharma's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

LTR Pharma  (ASX:LTP) Total Assets Explanation

Total Assets is connected with ROA %.

LTR Pharma's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-11.522/( (32.211+27.323)/ 2 )
=-11.522/29.767
=-38.71 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

LTR Pharma's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.074/( (32.211+27.323)/ 2 )
=0.074/29.767
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

LTR Pharma Total Assets Related Terms

LTR Pharma Total Assets Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Total Assets Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
0.42 2.25 7.51 3.37 32.21

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial 6.61 3.37 34.73 32.21 27.32
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

LTR Pharma's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=31.511+0.701
=32.21

LTR Pharma's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=26.865+0.458
=27.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$27.32 Mil mean?
LTR Pharma (ASX:LTP) has a Total Assets of A$27.32 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Total Assets too high?
LTR Pharma's current Total Assets is A$27.32 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Total Assets compare to VRTX and REGN?
LTR Pharma's Total Assets of A$27.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on LTR Pharma and its competitors. LTR Pharma's current Total Assets is A$27.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Total Assets of A$27.32 Mil. The current Total Assets is A$27.32 Mil. LTR Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Total Assets is A$27.32 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price